Articles by Justin Heifetz
Austria-based vaccinemaker Affiris announced that its Parkinson's disease vaccine has met its primary endpoint in a small Phase I safety trial of patients receiving two different doses of the jab.
Chikungunya fever is a dangerous tropical virus that has recently surfaced in the U.S. after erupting in the Caribbean. But Austria-based Themis Bioscience may eventually have a way to combat it, new data suggest.
This week, the company's VGX Animal Health subsidiary sold its animal health assets--including an exclusive license with Inovio for animal DNA vaccines--to South Korea's Plumbline Life Sciences.